CAIHL read · Jun 5, 2026
GC Green Cross Develops 'RegulAItor' AI Chatbot for Pharmaceutical Regulatory Affairs
Framework
What CAIHL does
Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.
The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.
This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.
The four dimensions
How this item reads through CAIHL
Primary user
mixed
Both patients and clinicians interact directly with this AI.
Hosting
institutional
Hosted inside a health system, insurer, or large employer. Access controlled by the institution.
Interests
commercial
Prioritizes vendor or platform commercial interests (advertising, data, retention).
Agency
expanding
Expands patient capabilities, supports their questions, increases their ability to act on their own values across and beyond health systems.
Editor's CAIHL read
One-sentence synthesis
Industry-internal regulatory AI; patient-distant but compresses the document chain that produces the label the patient reads.
In the scan
How this item appeared in the daily scan
Editor's note: The Korean rollout pattern — regulatory back office first, patient-facing later — is the inverse of the US pattern, where consumer chatbots arrived first and the regulatory documentation is catching up.
Summary: Aju Business Daily (KR): South Korean pharma GC Green Cross launches RegulAItor, an internal AI chatbot for navigating pharmaceutical regulatory submissions — an industrial-back-office product, not a patient-facing one, but it normalizes AI in the document chain the patient eventually receives.
methodology
Limitations
CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.